News

Zoledronic Acid Cuts Fractures at All Risk Levels

Publish date: March 1, 2011
PDF Download

 

From the Annual Meeting of the American Society for Bone and Mineral Research

It is not necessary to target treatment to women with an especially elevated fracture risk.

Source DR. CAULEY

Pages

Recommended Reading

Atypical Breaks Tied to Time on Bisphosphonates
MDedge Endocrinology
Hip Fracture Rates Rose as Use of HT Waned
MDedge Endocrinology
Check BMD After 3 Months of Amenorrhea
MDedge Endocrinology
Visceral Obesity Linked to Osteoporosis Before Menopause
MDedge Endocrinology
Short-Acting Opioids Up Fracture Risk in Elderly
MDedge Endocrinology
Casual Sun Exposure Yields Inadequate Vit. D
MDedge Endocrinology
New Guidance Aids Osteoporosis Screening
MDedge Endocrinology
Denosumab Gains New Indication, for Bone Metastases
MDedge Endocrinology
Local Corticosteroids Slowed RA Hand Bone Loss
MDedge Endocrinology
Targeted Interventions Improve Hip Fracture Outcomes
MDedge Endocrinology